Navigation Links
Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti

ABBOTT PARK, Ill., Jan. 13 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and its philanthropic foundation the Abbott Fund have committed to provide $1 million in initial humanitarian aid in response to the earthquake in Haiti.  This support includes grant funding and donations of critical pharmaceutical and nutritional products to strengthen the ability of humanitarian aid organizations to respond to immediate health needs in Haiti.  This includes an initial quantity of pharmaceutical and nutritional products that are already in use in a hospital in Haiti.

These relief efforts in Haiti build on Abbott's existing philanthropic partnerships to expand access to health care in the country.  Since 2007, Abbott and the Abbott Fund have provided more than $34 million in grants and product donations to help address health needs in Haiti, including maternal and child health, diabetes, HIV/AIDS and malnutrition.

"The recent earthquake has had a devastating impact on Haiti's limited health care system, which was already facing significant challenges," said Catherine V. Babington, president, the Abbott Fund.  "Building on our existing partnerships with humanitarian organizations in Haiti, we are providing funding and product donations to help address the immense and immediate health needs."

Initial support from the Abbott Fund for earthquake recovery efforts includes $100,000 in grants to three of Abbott's trusted humanitarian aid partners: American Red Cross, Partners In Health and Catholic Medical Mission Board.  All of these organizations have an established presence in Haiti, and are already mobilizing relief efforts in the country.

Abbott also is actively working with AmeriCares, Direct Relief International and additional organizations to identify and distribute critical nutritional and pharmaceutical products, such as antibiotics and rehydration fluids, that will provide immediate relief for people affected by the earthquake in Haiti.  Abbott will continue to work with key humanitarian aid partners to assess ongoing needs and the state of the transportation infrastructure to move forward with relief efforts.

In addition, Abbott volunteers in the Dallas area will be supporting the efforts of the American Red Cross to respond to the disaster in Haiti.  Through the American Red Cross program, "Ready When the Time Comes," 35 Abbott volunteers have received training over the past year, and are already assisting with fundraising and other efforts in Dallas to support American Red Cross relief programs on the ground in Haiti.

About Abbott and Abbott Fund

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs more than 72,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at

The Abbott Fund is a philanthropic foundation established by Abbott in 1951.  The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to health care and strengthen communities worldwide.  For more information on the Abbott Fund, visit




Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: